- Summary
- Actions
- Committee Votes
- Floor Votes
- Memo
- Text
- LFIN
- Chamber Video/Transcript
S08921 Summary:
BILL NO | S08921 |
  | |
SAME AS | No Same As |
  | |
SPONSOR | PARKER |
  | |
COSPNSR | |
  | |
MLTSPNSR | |
  | |
  | |
Directs the commissioner of health to conduct a sickle cell disparity study. |
S08921 Actions:
BILL NO | S08921 | |||||||||||||||||||||||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||||||||||||||||||||||
03/28/2024 | REFERRED TO HEALTH |
S08921 Committee Votes:
Go to topS08921 Floor Votes:
There are no votes for this bill in this legislative session.
Go to topS08921 Text:
Go to top STATE OF NEW YORK ________________________________________________________________________ 8921 IN SENATE March 28, 2024 ___________ Introduced by Sen. PARKER -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT in relation to directing the commissioner of health to conduct a sickle cell disparity study; and providing for the repeal of such provisions upon expiration thereof The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. 1. The commissioner of health is authorized and directed to 2 conduct a sickle cell disparity study. 3 2. Such study shall determine whether there is a disparity between 4 treatment accessibility and affordability for persons with sickle cell 5 disease and persons with other chronic illnesses, including but not 6 limited to lupus, cancer, diabetes, and heart disease. 7 3. Not later than eighteen months after the effective date of this 8 act, the commissioner shall post the results of such study on the open 9 health data section of the department of health's website. 10 § 2. This act shall take effect immediately and shall expire and be 11 deemed repealed two years after such effective date. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD14371-01-4